Biomarkers and response to bevacizumab--response

Clin Cancer Res. 2014 Feb 15;20(4):1058. doi: 10.1158/1078-0432.CCR-13-3269.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Biomarkers, Tumor / blood*
  • Fallopian Tube Neoplasms / blood*
  • Female
  • Humans
  • Ovarian Neoplasms / blood*
  • Patient Selection*
  • Peritoneal Neoplasms / blood*

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized
  • Biomarkers, Tumor